Biogen has arrived at a highly unusual solution to a dispute surrounding a patent for its blockbuster multiple sclerosis drug Tecfidera. It has agreed to pay Denmark’s Forward Pharma $1.25 ...
After hours: March 19 at 4:05:13 PM EDT Loading Chart for GPK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback